Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Management of epilepsy during pregnancy: an update.

Patel SI, Pennell PB.

Ther Adv Neurol Disord. 2016 Mar;9(2):118-29. doi: 10.1177/1756285615623934. Epub 2015 Dec 27. Review.

2.

Development of Physiologically Based Pharmacokinetic/Pharmacodynamic Model for Indomethacin Disposition in Pregnancy.

Alqahtani S, Kaddoumi A.

PLoS One. 2015 Oct 2;10(10):e0139762. doi: 10.1371/journal.pone.0139762. eCollection 2015.

3.

Antiepileptic drugs in women with epilepsy during pregnancy.

Gedzelman E, Meador KJ.

Ther Adv Drug Saf. 2012 Apr;3(2):71-87. doi: 10.1177/2042098611433192. Review.

4.

MODEL-BASED LAMOTRIGINE CLEARANCE CHANGES DURING PREGNANCY: CLINICAL IMPLICATION.

Polepally AR, Pennell PB, Brundage RC, Stowe ZN, Newport DJ, Viguera AC, Ritchie JC, Birnbaum AK.

Ann Clin Transl Neurol. 2014 Feb;1(2):99-106.

5.

Human UGT1A4 and UGT1A3 conjugate 25-hydroxyvitamin D3: metabolite structure, kinetics, inducibility, and interindividual variability.

Wang Z, Wong T, Hashizume T, Dickmann LZ, Scian M, Koszewski NJ, Goff JP, Horst RL, Chaudhry AS, Schuetz EG, Thummel KE.

Endocrinology. 2014 Jun;155(6):2052-63. doi: 10.1210/en.2013-2013. Epub 2014 Mar 18.

6.

Pharmacotherapy for mood disorders in pregnancy: a review of pharmacokinetic changes and clinical recommendations for therapeutic drug monitoring.

Deligiannidis KM, Byatt N, Freeman MP.

J Clin Psychopharmacol. 2014 Apr;34(2):244-55. doi: 10.1097/JCP.0000000000000087. Review.

7.

Pharmacogenetics and individualizing drug treatment during pregnancy.

Haas DM.

Pharmacogenomics. 2014 Jan;15(1):69-78. doi: 10.2217/pgs.13.228. Review.

8.

Influence of gestational age and body weight on the pharmacokinetics of labetalol in pregnancy.

Fischer JH, Sarto GE, Hardman J, Endres L, Jenkins TM, Kilpatrick SJ, Jeong H, Geller S, Deyo K, Fischer PA, Rodvold KA.

Clin Pharmacokinet. 2014 Apr;53(4):373-83. doi: 10.1007/s40262-013-0123-0.

9.

Lamotrigine dosing for pregnant patients with bipolar disorder.

Clark CT, Klein AM, Perel JM, Helsel J, Wisner KL.

Am J Psychiatry. 2013 Nov;170(11):1240-7. doi: 10.1176/appi.ajp.2013.13010006.

10.

Antiepileptic drug clearance and seizure frequency during pregnancy in women with epilepsy.

Reisinger TL, Newman M, Loring DW, Pennell PB, Meador KJ.

Epilepsy Behav. 2013 Oct;29(1):13-8. doi: 10.1016/j.yebeh.2013.06.026. Epub 2013 Aug 2.

11.

Regulation of hepatic phase II metabolism in pregnant mice.

Wen X, Donepudi AC, Thomas PE, Slitt AL, King RS, Aleksunes LM.

J Pharmacol Exp Ther. 2013 Jan;344(1):244-52. doi: 10.1124/jpet.112.199034. Epub 2012 Oct 10.

12.

Transitional polytherapy: tricks of the trade for monotherapy to monotherapy AED conversions.

Garnett WR, St Louis EK, Henry TR, Bramley T.

Curr Neuropharmacol. 2009 Jun;7(2):83-95. doi: 10.2174/157015909788848884.

13.

Requirements for generic anti-epileptic medicines: a regulatory perspective.

Maliepaard M, Hekster YA, Kappelle A, van Puijenbroek EP, Elferink AJ, Welink J, Gispen-de Wied CC, Lekkerkerker FJ.

J Neurol. 2009 Dec;256(12):1966-71. doi: 10.1007/s00415-009-5231-2. Epub 2009 Jul 15. Review. No abstract available.

14.

Practice parameter update: management issues for women with epilepsy--focus on pregnancy (an evidence-based review): vitamin K, folic acid, blood levels, and breastfeeding: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society.

Harden CL, Pennell PB, Koppel BS, Hovinga CA, Gidal B, Meador KJ, Hopp J, Ting TY, Hauser WA, Thurman D, Kaplan PW, Robinson JN, French JA, Wiebe S, Wilner AN, Vazquez B, Holmes L, Krumholz A, Finnell R, Shafer PO, Le Guen C; American Academy of Neurology; American Epilepsy Society.

Neurology. 2009 Jul 14;73(2):142-9. doi: 10.1212/WNL.0b013e3181a6b325. Epub 2009 Apr 27. Review.

15.

Antiepileptic drugs during pregnancy: what is known and which AEDs seem to be safest?

Pennell PB.

Epilepsia. 2008 Dec;49 Suppl 9:43-55. doi: 10.1111/j.1528-1167.2008.01926.x. Review.

16.

Pregnancy, epilepsy, and anticonvulsants.

Steinhoff BJ.

Dialogues Clin Neurosci. 2008;10(1):63-75. Review.

17.

Hormones, seizures, and lamotrigine: Oh, my!

Pennell PB.

Epilepsy Curr. 2008 Jan-Feb;8(1):8-10. doi: 10.1111/j.1535-7511.2007.00217.x. No abstract available.

18.

Identification of human UDP-glucuronosyltransferases catalyzing hepatic 1alpha,25-dihydroxyvitamin D3 conjugation.

Hashizume T, Xu Y, Mohutsky MA, Alberts J, Hadden C, Kalhorn TF, Isoherranen N, Shuhart MC, Thummel KE.

Biochem Pharmacol. 2008 Mar 1;75(5):1240-50. doi: 10.1016/j.bcp.2007.11.008. Epub 2007 Nov 22.

19.

Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency.

Pennell PB, Peng L, Newport DJ, Ritchie JC, Koganti A, Holley DK, Newman M, Stowe ZN.

Neurology. 2008 May 27;70(22 Pt 2):2130-6. Epub 2007 Nov 28.

20.

Epilepsy in pregnancy.

Tomson T, Hiilesmaa V.

BMJ. 2007 Oct 13;335(7623):769-73. Review. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk